Muscular Dystrophy tests in Dubai & UAE

Compare available Muscular Dystrophy tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

1,700.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Muscular Dystrophy test prices

Showing 1–14 of 14 matching tests.

Muscular Dystrophy diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4812 CAPN3 Gene Limb-Girdle Muscular Dystrophy Type 2A (LGMD2A) Next-Generation Sequencing DNA Test This test analyzes the CAPN3 gene to identify pathogenic variants associated with Limb-Girdle Muscular Dystrophy Type 2A (LGMD2A). It detects mutations responsible for a progressiv...	Whole Blood, Extracted DNA, or One Drop Blood on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CAPN3 gene", "Full coding region analysis of CAPN3"] Parameters [] Preparation ["No fasting required", "No specific medication or diet restrictions"] Indications ["Individuals with clinical suspicion of LGMD2A", "Family history of LGMD2A", "Carrier screening in consanguineous families"] Measurement technique Confirm with laboratory Codes LOINC: 81644-7 ICD-10: G71.09, Z13.71, Z31.430 Clinical summary This test analyzes the CAPN3 gene to identify pathogenic variants associated with Limb-Girdle Muscular Dystrophy Type 2A (LGMD2A). It detects mutations responsible for a progressive muscle-wasting disorder.
TEST-5158 CHKB Gene Congenital Megaconial Muscular Dystrophy Genetic Test This genetic test evaluates the CHKB gene for pathogenic variants associated with congenital megaconial muscular dystrophy.	Whole Blood, Dried Blood Spot (FTA Card), Extracted DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CHKB gene coding region variants", "Pathogenic variants"] Parameters [] Preparation ["No specific fasting required", "Inform lab of current anticoagulant therapy"] Indications ["Suspected congenital megaconial muscular dystrophy", "Family history of the condition", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 94856-0 ICD-10: G71.2 Clinical summary This genetic test evaluates the CHKB gene for pathogenic variants associated with congenital megaconial muscular dystrophy.
TEST-5932 COL6A2 (Ullrich Congenital Muscular Dystrophy) Genetic Test This genetic test evaluates the COL6A2 gene for mutations associated with Ullrich congenital muscular dystrophy.	Peripheral whole blood (EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["COL6A2 gene sequence", "Copy number variations (CNV) in COL6A2"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medications without consulting your physician"] Indications ["Suspected Ullrich congenital muscular dystrophy", "Family history of collagen VI-related myopathies", "Need for definitive genetic diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 100049-4 ICD-10: G71.0 Clinical summary This genetic test evaluates the COL6A2 gene for mutations associated with Ullrich congenital muscular dystrophy.
TEST-3957 COL6A3 Gene Genetic Test for Bethlem Myopathy Type 1 This test evaluates the COL6A3 gene for pathogenic variants associated with Bethlem myopathy type 1.	Peripheral whole blood, serum, plasma, or FTA card specimen	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COL6A3 gene", "Single nucleotide variants", "Small insertions and deletions", "Structural rearrangements", "Copy number variants"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication"] Indications ["Suspected Bethlem myopathy type 1", "Family history of Bethlem myopathy type 1", "Carrier screening", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 21665-9 ICD-10: G71.0 Clinical summary This test evaluates the COL6A3 gene for pathogenic variants associated with Bethlem myopathy type 1.
TEST-5281 DAG1 Gene Muscular Dystrophy-Dystroglycanopathy (Limb-Girdle), Type C9 Genetic Test This test identifies pathogenic variants in the DAG1 gene associated with limb-girdle muscular dystrophy-dystroglycanopathy type C9.	Whole Blood (EDTA), Dried Blood Spot (FTA card), or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DAG1 gene", "Copy number variants (CNVs) in the DAG1 gene"] Parameters [] Preparation [] Indications ["Suspected limb-girdle muscular dystrophy-dystroglycanopathy type C9", "Family history suggestive of dystroglycanopathy"] Measurement technique Confirm with laboratory Codes LOINC: 92951-2 ICD-10: G71.0 Clinical summary This test identifies pathogenic variants in the DAG1 gene associated with limb-girdle muscular dystrophy-dystroglycanopathy type C9.
TEST-4722 DYSF Gene Limb‑Girdle Muscular Dystrophy Type 2B (LGMD2B/R2) Genetic Test This genetic test identifies pathogenic variants in the DYSF gene associated with Limb-Girdle Muscular Dystrophy Type 2B (LGMD2B/R2). It provides a definitive diagnosis for individ...	Peripheral whole blood (EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DYSF gene", "Copy Number Variants (CNV) in the DYSF gene"] Parameters [] Preparation ["No fasting required", "Maintain normal hydration", "Provide a detailed clinical history"] Indications ["Suspected Limb-Girdle Muscular Dystrophy Type 2B (LGMD2B/R2)", "Family history compatible with LGMD2B/R2"] Measurement technique Confirm with laboratory Codes LOINC: 82204-3 ICD-10: G71.0 Clinical summary This genetic test identifies pathogenic variants in the DYSF gene associated with Limb-Girdle Muscular Dystrophy Type 2B (LGMD2B/R2). It provides a definitive diagnosis for individuals suspected of having dysferlinopathy.
TEST-4361 FHL1 Gene Emery-Dreifuss Muscular Dystrophy Type 6 Genetic Test This test evaluates the FHL1 gene for pathogenic variants associated with Emery-Dreifuss Muscular Dystrophy Type 6 (EDMD6).	Peripheral Whole Blood (3-5 mL in EDTA tube) or FTA Card (Dried Blood Spot)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FHL1 gene", "Sequence variants", "Copy number variants"] Parameters [] Preparation ["Hydration recommended", "Genetic counselling session beforehand can be arranged"] Indications ["Suspected Emery-Dreifuss Muscular Dystrophy Type 6 (EDMD6)", "Family history of EDMD6", "Need for accurate diagnosis for tailored management", "Family screening"] Measurement technique Confirm with laboratory Codes LOINC: 51969-4 ICD-10: G71.09 Clinical summary This test evaluates the FHL1 gene for pathogenic variants associated with Emery-Dreifuss Muscular Dystrophy Type 6 (EDMD6).
TEST-425 Limb‑Girdle Muscular Dystrophy (LGMD) Genetic Testing Test This test identifies genetic mutations in over 30 genes associated with Limb-Girdle Muscular Dystrophy (LGMD) using Next-Generation Sequencing (NGS). It helps confirm a diagnosis i...	Peripheral Whole Blood	21 Days	1,700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single-nucleotide variants", "Small insertions or deletions", "Copy number variations", "Coding exons", "Splice sites"] Parameters [] Preparation ["No fasting required", "No special preparation required", "Submit complete family history and relevant clinical notes prior to collection"] Indications ["Clinical suspicion of Limb-Girdle Muscular Dystrophy (LGMD)", "Progressive proximal muscle weakness", "Family history of muscular dystrophy", "Need for definitive diagnosis for management and genetic counseling"] Measurement technique Confirm with laboratory Codes LOINC: 94230-1 ICD-10: G71.0 Clinical summary This test identifies genetic mutations in over 30 genes associated with Limb-Girdle Muscular Dystrophy (LGMD) using Next-Generation Sequencing (NGS). It helps confirm a diagnosis in patients with suspected LGMD based on clinical presentation.
TEST-4801 MYOT Gene LGMD1A NGS Test This test identifies pathogenic mutations in the MYOT gene associated with Limb-Girdle Muscular Dystrophy Type 1A (LGMD1A).	Peripheral Whole Blood or DNA FTA Card Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MYOT gene", "Single-nucleotide variants (SNVs)", "Small insertions or deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["No fasting or special preparation is necessary."] Indications ["Suspected diagnosis of Limb-Girdle Muscular Dystrophy Type 1A (LGMD1A)", "Family history of LGMD1A", "Genetic counseling for individuals with neuromuscular symptoms"] Measurement technique Confirm with laboratory Codes LOINC: 21770-2 ICD-10: G71.0 Clinical summary This test identifies pathogenic mutations in the MYOT gene associated with Limb-Girdle Muscular Dystrophy Type 1A (LGMD1A).
TEST-5184 POMGNT1 Gene Analysis for Muscular Dystrophy-Dystroglycanopathy, Congenital with Intellectual Disability, Type B3 (Genetic Test) This genetic test analyzes the POMGNT1 gene to detect mutations causing congenital muscular dystrophy-dystroglycanopathy type B3 with intellectual disability.	Peripheral whole blood (EDTA) or buccal swab	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["POMGNT1 gene variants", "Pathogenic mutations"] Parameters [] Preparation ["Fasting is not required", "Inform phlebotomist of anticoagulant use"] Indications ["Suspected muscular dystrophy-dystroglycanopathy type B3", "Family history of related disorders", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 21690-2 ICD-10: G71.0 Clinical summary This genetic test analyzes the POMGNT1 gene to detect mutations causing congenital muscular dystrophy-dystroglycanopathy type B3 with intellectual disability.
TEST-5270 POMGNT2 Gene Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A8 Genetic Test This test identifies pathogenic variants within the POMGNT2 gene associated with congenital muscular dystrophy-dystroglycanopathy type A8.	Whole blood in EDTA tube, extracted genomic DNA, or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the POMGNT2 gene", "Exonic and splice-site variants"] Parameters [] Preparation ["No specific fasting required", "Genetic counselling recommended before collection"] Indications ["Suspected congenital muscular dystrophy-dystroglycanopathy type A8", "Clinical presentation consistent with brain and eye anomalies associated with POMGNT2 mutations"] Measurement technique Confirm with laboratory Codes LOINC: 90590-1 ICD-10: G71.2 Clinical summary This test identifies pathogenic variants within the POMGNT2 gene associated with congenital muscular dystrophy-dystroglycanopathy type A8.
TEST-5277 POMT2 Gene Muscular Dystrophy-Dystroglycanopathy (Limb-Girdle), Type C2 Genetic Test This test sequences the entire coding region of the POMT2 gene to identify pathogenic mutations associated with limb-girdle muscular dystrophy-dystroglycanopathy type C2.	Blood / FTA Card / DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["POMT2 gene sequence", "Pathogenic mutations in POMT2"] Parameters [{"name": "Depth of Coverage", "reference_range": "≥100× for all coding nucleotides"}] Preparation ["No fasting required", "Hydrate well before sample collection", "Have Emirates ID ready for verification"] Indications ["Suspected diagnosis of LGMD-dystroglycanopathy type C2", "Family history of LGMD-dystroglycanopathy type C2"] Measurement technique Confirm with laboratory Codes LOINC: 82959-1 ICD-10: G71.0 Clinical summary This test sequences the entire coding region of the POMT2 gene to identify pathogenic mutations associated with limb-girdle muscular dystrophy-dystroglycanopathy type C2.
TEST-5563 SELENON Gene Rigid Spine Muscular Dystrophy Genetic Test This genetic test identifies pathogenic variants in the SELENON gene associated with Rigid Spine Muscular Dystrophy type 1 (RSMD1).	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SELENON gene", "Copy Number Variations (CNV) in the SELENON gene"] Parameters [] Preparation ["No fasting required", "No medication changes required", "Mandatory pre-test genetic counselling session"] Indications ["Individuals with clinical symptoms suggestive of RSMD1", "Family members of individuals diagnosed with RSMD1", "Carrier screening in families with a history of RSMD1"] Measurement technique Confirm with laboratory Codes LOINC: 92709-7 ICD-10: G71.0 Clinical summary This genetic test identifies pathogenic variants in the SELENON gene associated with Rigid Spine Muscular Dystrophy type 1 (RSMD1).
TEST-4747 TRAPPC11 Gene Limb‑Girdle Muscular Dystrophy, Autosomal Recessive Type 2S (LGMD‑2S) Genetic Test This genetic test identifies variants in the TRAPPC11 gene associated with Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2S (LGMD-2S).	Whole Blood, DNA FTA Card, or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TRAPPC11 gene variants", "Single nucleotide variants", "Insertions", "Deletions", "Copy number variations"] Parameters [] Preparation ["No fasting required", "No medication discontinuation necessary"] Indications ["Suspected diagnosis of LGMD-2S", "Family history of LGMD-2S", "Genetic counseling for family planning"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: G71.0 Clinical summary This genetic test identifies variants in the TRAPPC11 gene associated with Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2S (LGMD-2S).

Category overview

Muscular Dystrophy: overview

Coping with progressive muscle weakness, frequent falls, or delayed motor milestones in a child requires highly specific diagnostic clarity to unlock the most effective neurological and physical care. Within our specialized neurogenetics department, testing for Muscular Dystrophy evaluates your DNA for inherited mutations that damage the critical proteins needed for healthy muscle fiber structure. Utilizing cutting-edge diagnostic technology, this vital molecular screening helps confirm conditions like Duchenne or Becker muscular dystrophy, providing the definitive data needed to safely guide personalized physical therapy, proactive cardiac and respiratory monitoring, and targeted genetic therapies where available. Recognized for sensitive neuromuscular diagnostics among premier diagnostic labs in Dubai and the UAE, DNA Labs ensures absolute patient confidentiality, uncompromising diagnostic accuracy, and prompt turnaround times. Take control of your neuromuscular health—book your muscular dystrophy testing in UAE, arrange a secure clinical sample collection, or reach out to our dedicated medical team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.